US Patent Issued to Merus on June 30 for "Antibodies that bind EGFR and cMET" (Dutch Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,638, issued on June 30, was assigned to Merus B.V. (Utrecht, Netherlands).

"Antibodies that bind EGFR and cMET" was invented by Cecilia Anna Wilhelmina Geuijen (Utrecht, Netherlands), Robertus Cornelis Roovers (Utrecht, Netherlands), Mark Throsby (Utrecht, Netherlands), Cornelis Adriaan De Kruif (Utrecht, Netherlands) and Ton Logtenberg (Utrecht, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention as disclosed herein relates to bispecific antibodies that comprises a first variable domain that can bind an extracellular part of epidermal growth factor receptor (EGFR) and a second variable domain that can bind an extracellular part...